Results 61 to 70 of about 23,074,058 (199)

Causal inference tools for pharmacovigilance: using causal graphs to identify and address biases in disproportionality analysis.

Introduction: Disproportionality analysis, finding associations in the co-reporting of drugs and events, is used in pharmacovigilance to detect signals of potential adverse drug reactions.
Joseph Mitchell, Michele Fusaroli, Annette Rudolph, Elena Rocca, Riccardo Fusaroli   +4 more
core   +2 more sources

Risk of pulmonary fungal infections associated with biologics: a FAERS database disproportionality analysis

Frontiers in Immunology
Objectivebiologics have significantly advanced the treatment of rheumatoid arthritis (RA) and psoriatic arthritis (PsA). However, real-world data regarding the risks of pulmonary fungal infections (PFI) associated with different biologics are limited ...
Jing Li, Zhi Wu Han, Shan Shan Gao, Qie Guo, Huai Qin Cang   +4 more
doaj   +1 more source

Discretion and gender disproportionality in police disciplinary systems

, 2000
Police supervisor decision making with regard to disciplinary action has received scant empirical study in general, and has yet to be examined across gender.
Jack R. Greene, Piquero, Alex R, Matthew J. Hickman, Greene, Jack R, Alex R. Piquero, Hickman, Matthew J   +5 more
core   +1 more source

The Distributional Impact of the Norwegian Tax Reform Measured by Disproportionality [PDF]

, 1995
This paper focuses on the measurement of progressivity and the distributional effect of the Norwegian tax reform of 1992. Progressivity is measured by the degree of disproportionality, which implies that the burden of taxes is estimated when income units
Thoresen, Thor Olav
core  

Therapeutic Ineffectiveness of Calcitonin Gene-Related Peptide Antagonists: A Real-World Pharmacovigilance Analysis

Cyprus Journal of Medical Sciences
BACKGROUND/AIMS: Migraine is treated with a variety of drugs with different pharmacological mechanisms of action. Among these drugs, calcitonin gene-related peptide (CGRP) antagonists represent a novel approach to the treatment of migraine.
Nesrin Çağlayan Duman
doaj   +1 more source

Pulmonary arterial hypertension and trastuzumab: a disproportionality analysis in the WHO pharmacovigilance database.

Hypothesis generating disproportionality analysis to calculate signals of disproportionate reporting between trastuzumab, trastuzumab emtansine and trastuzumab deruxtecan and pulmonary arterial hypertenson in the WHO pharmacovigilance ...
MONTANI David, Charles Khouri
core   +2 more sources

Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis

Drug Safety
No abstract ...
Raschi E., Salvo F., Bate A., De Ponti F., Poluzzi E., Tuccori M., van Puijenbroek E., Joshi N., Khouri C.   +8 more
openaire   +5 more sources

School Counselors and the Disproportionality Dilemma: A Multilevel Analysis [PDF]

, 2018
For decades, disproportionality has been explored by educational researchers in special education and school discipline. Researchers have devoted far less attention to disproportionality in school counselor referral.
Brodar, Jennifer R
core  

Comparison of safety of lecanemab and donanemab: a real-world disproportionality analysis using the FDA adverse event reporting system

Frontiers in Pharmacology
BackgroundLecanemab and donanemab are anti-amyloid-β (Aβ) monoclonal antibodies recently approved for the treatment of Alzheimer’s disease (AD). Although both agents have demonstrated therapeutic potential, their post-marketing adverse event reporting ...
Xiuping Feng, Xiuping Feng, Shangqing Bi, Shangqing Bi, Chaoqiong Shi, Chaoqiong Shi, Qingqing Chang, Qingqing Chang, Jiaming Zhang, Jiaming Zhang, Yiyang Zhuang, Yiyang Zhuang   +11 more
doaj   +1 more source

Table_1_Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System.xlsx

, 2019
Spontaneous reporting systems may generate a large volume of information in real world conditions with a relatively low cost. Disproportionality measures are useful to indicate and quantify unexpected safety issues associated with a given drug-event pair
Flávia Campos Barcelos (6680120), Mario Jorge Sobreira da Silva (6639692), Elisangela da Costa Lima (6680129), Guacira Corrêa de Matos (6680123), Fabrício Alves Barbosa da Silva (6680126)   +4 more
core   +1 more source